Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples

by Thomas Liechti, Yaser Iftikhar, Massimo Mangino, Margaret Beddall, Charles W. Goss, Jane A. O’Halloran, Philip A. Mudd, Mario Roederer
Published 2022-11-01

Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection

by Marios Koutsakos, Jackson S Turner, M Cristina Vazquez Guillamet, Daniel Reynolds, Tingting Lei, Derek E Byers, Ali H Ellebedy, Philip A Mudd
Published 2023-01-01

Predicting severe disease in patients diagnosed with seasonal influenza in the emergency department

by Michael J. Pajor, Satish Munigala, Dan Reynolds, Julie Zeigler, Danaye Gebru, Phillip V. Asaro, Steven J. Lawrence, Stephen Y. Liang, Philip A. Mudd
Published 2023-10-01

SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response

by Jackson S. Turner, Aaron Day, Wafaa B. Alsoussi, Zhuoming Liu, Jane A. O’Halloran, Rachel M. Presti, Bruce K. Patterson, Sean P. J. Whelan, Ali H. Ellebedy, Philip A. Mudd
Published 2021-01-01

Acute phase CD8+ T lymphocytes against alternate reading frame epitopes select for rapid viral escape during SIV infection.

by Andrew D Walsh, Benjamin N Bimber, Arpita Das, Shari M Piaskowski, Eva G Rakasz, Alexander T Bean, Philip A Mudd, Adam J Ericsen, Nancy A Wilson, Austin L Hughes, David H O'Connor, Nicholas J Maness
Published 2013-01-01

Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 R...

by M. Cristina Vazquez Guillamet, MD, Hrishikesh S. Kulkarni, MD, MSCI, Kevin Montes, MD, Maanasi Samant, MD, Preet A. Shaikh, MD, Kevin Betthauser, PharmD, Philip A. Mudd, MD, PhD, Daniel Reynolds, MD, Jane O’Halloran, MD, PhD, Patrick Lyons, MD, Colleen McEvoy, MD, Rodrigo Vazquez Guillamet, MD
Published 2021-02-01

Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19

by Davide Scozzi, Marlene Cano, Lina Ma, Dequan Zhou, Ji Hong Zhu, Jane A. O’Halloran, Charles Goss, Adriana M. Rauseo, Zhiyi Liu, Sanjaya K. Sahu, Valentina Peritore, Monica Rocco, Alberto Ricci, Rachele Amodeo, Laura Aimati, Mohsen Ibrahim, Ramsey Hachem, Daniel Kreisel, Philip A. Mudd, Hrishikesh S. Kulkarni, Andrew E. Gelman
Published 2021-02-01

Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer’s and coronary disease pathways

by Lihua Wang, Daniel Western, Jigyasha Timsina, Charlie Repaci, Won-Min Song, Joanne Norton, Pat Kohlfeld, John Budde, Sharlee Climer, Omar H. Butt, Daniel Jacobson, Michael Garvin, Alan R. Templeton, Shawn Campagna, Jane O’Halloran, Rachel Presti, Charles W. Goss, Philip A. Mudd, Beau M. Ances, Bin Zhang, Yun Ju Sung, Carlos Cruchaga
Published 2023-04-01

SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients

by Frank J. Lin, Alexa Michelle Altman Doss, Hannah G. Davis-Adams, Lucas J. Adams, Christopher H. Hanson, Laura A. VanBlargan, Chieh-Yu Liang, Chieh-Yu Liang, Rita E. Chen, Rita E. Chen, Jennifer Marie Monroy, H. James Wedner, Anthony Kulczycki, Tarisa L. Mantia, Caitlin C. O’Shaughnessy, Saravanan Raju, Fang R. Zhao, Elise Rizzi, Christopher J. Rigell, Tiffany Biason Dy, Andrew L. Kau, Andrew L. Kau, Zhen Ren, Jackson S. Turner, Jane A. O’Halloran, Rachel M. Presti, Rachel M. Presti, Daved H. Fremont, Peggy L. Kendall, Ali H. Ellebedy, Ali H. Ellebedy, Ali H. Ellebedy, Philip A. Mudd, Philip A. Mudd, Michael S. Diamond, Michael S. Diamond, Michael S. Diamond, Michael S. Diamond, Michael S. Diamond, Ofer Zimmerman, Brian J. Laidlaw
Published 2022-12-01

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

by Kenneth E. Remy, Monty Mazer, David A. Striker, Ali H. Ellebedy, Andrew H. Walton, Jacqueline Unsinger, Teresa M. Blood, Philip A. Mudd, Daehan J. Yi, Daniel A. Mannion, Dale F. Osborne, R. Scott Martin, Nitin J. Anand, James P. Bosanquet, Jane Blood, Anne M. Drewry, Charles C. Caldwell, Isaiah R. Turnbull, Scott C. Brakenridge, Lyle L. Moldwawer, Richard S. Hotchkiss
Published 2021-02-01

CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

by Bruce K. Patterson, Harish Seethamraju, Kush Dhody, Michael J. Corley, Kazem Kazempour, Jay Lalezari, Alina P.S. Pang, Christopher Sugai, Eisa Mahyari, Edgar B. Francisco, Amruta Pise, Hallison Rodrigues, Helen L. Wu, Gabriela M. Webb, Byung S. Park, Scott Kelly, Nader Pourhassan, Alina Lelic, Lama Kdouh, Monica Herrera, Eric Hall, Benjamin N. Bimber, Matthew Plassmeyer, Raavi Gupta, Oral Alpan, Jane A. O’Halloran, Philip A. Mudd, Enver Akalin, Lishomwa C. Ndhlovu, Jonah B. Sacha
Published 2021-02-01